WELVASTA-10 contains Rosuvastatin 10 mg, a potent statin formulation intended to reduce LDL cholesterol and support cardiovascular risk management. It is well suited to a focused PCD Cardiac-Diabetic portfolio.
LDL cholesterol.
Yes.
Yes, lifestyle modification remains important.
Take regularly as prescribed and follow lipid monitoring. Report unexplained or persistent muscle pain or weakness, particularly with dark urine.
Headache, nausea, abdominal discomfort and muscle pain may occur; liver enzyme elevations are possible. Rosuvastatin can rarely cause myopathy or rhabdomyolysis. (DailyMed)
WELVASTA-10: Rosuvastatin inhibits HMG-CoA reductase, reducing hepatic cholesterol synthesis and increasing LDL clearance from the bloodstream.
